Leaked Video Shows Facebook CEO Questioning "Long-Term Side Effects Of Modifying DNA" In COVID Vaccine Authored by Zachary Stieber via The Epoch Times, Facebook CEO Mark Zuckerberg made comments...
Maintaining antibodies in the blood requires creating certain long-lasting immune cells – but this doesn't always happen.
Vir Biotechnology and GlaxoSmithKline expanded a collaboration to develop strategies against COVID-19 to include work into new treatments for influenza and other respiratory viruses.
Graphene based COVID tests are quick and robust.
The head of the U.S. Centers for Disease Control and Prevention said on Feb. 14 it is “absolutely” too soon to lift mask mandates, citing daily...
The U.S. Food and Drug Administration approved Pfizer Inc.'s supplemental Biologics License Application for Panzyga to treat adult patients with a rare neurological disease of the...
Sanofi’s CEO, Paul Hudson, said that the mRNA-based COVID-19 vaccine developed with Translate Bio will not be ready this year
We mapped the genes of B cells to better understand why some develop immunity and others don't.
Editorial emphasizes need for global response Credit: NIAID WHAT: The rise of several significant variants of SARS-CoV-2, the virus that causes COVID-19, has attracted the attention...
Providing multivitamin and mineral supplements to the elderly could be a cheap way of boosting the protectiveness of COVID-19 vaccines.
The pandemic winter will take longer than we thought. The longer we struggle with the coronavirus, the brighter gold could shine. A long, long time ago,...
Credit: Mor M, et al., 2021, PLOS Pathogens, CCBY 4.0 (https://creativecommons.org/licenses/by/4.0/) The majority of the population can produce neutralizing antibodies against severe acute respiratory syndrome coronavirus...
New findings could deepen understanding of spread and inform public health policies Credit: Nik Anderson, www.vperemen.com A new computational analysis suggests that people under the age...
The arrival of COVID-19 vaccines has raised hope for an end to the pandemic. Hopefully that's true, but there are variables. Here are some factors that...
The end of the pandemic’s acute phase, or something genuinely close to it, will arrive when so-called herd immunity is reached....but when will that be?
The U.S. Food and Drug Administration granted Emergency Use Authorization (EUA) to a combination of Eli Lilly and AbCellera’s monoclonal antibody bamlanivimab and the Lilly antibody etesevimab...
J&J CEO Says Annual COVID-19 Vaccine Shot Will Be Required For Years
CNBC Transcript: Johnson & Johnson Chairman & CEO Alex Gorsky speaks with Meg Tirrell live during CNBC’s Healthy Returns Spotlight today on the company’s one-shot coronavirus...
Credit: Images by Jungsik Noh via GitHub DALLAS – Feb. 8, 2021 – World health experts have long suspected that the incidence of COVID-19 has been...
Scientists are working toward advances that, using nanotechnology, could lead to a hospital bed or doorknob that naturally destroys viruses. Credit: Sushma Kumari WASHINGTON, February 9,...
Credit: ETH Zurich /Giulia Marthaler Scientific and public health experts have been raising the alarm for decades, imploring public officials to prepare for the inevitability of...
LAMP and antigen COVID-19 tests promise inexpensive, accurate, and fast results to help manage the pandemic.
An international trial led by US experts is to begin testing AstraZeneca’s long-acting antibody combination therapy
Americans with excess weight and obesity have been hit hard by COVID-19. Now there is reason to believe they may not get the same protection from...
A member of the World Health Organization-led team visiting the central Chinese city of Wuhan said was surprised by the complexity of getting to the origins...
Less than one week after posting a positive first-look at Phase III vaccine data, Maryland-based Novavax began the rolling review process for authorization of NVX-CoV2373 in...
A new study report in Science suggests SARS-CoV-2 and its mutated new variants can evade immune responses via the selective deletion of small sections of the virus’s...
Vaccine developers pledge to create boosters that can better handle the new variants of the virus, and new data gives reassurance on the Oxford vaccine.
New research suggests that SARS-CoV-2 can evade immune responses, through a recurring pattern of evolution, by selectively deleting small bits of its genetic sequence. The deletions...
Other human coronaviruses just cause the common cold, and it's possible SARS-CoV-2 may one day be the same.